ALTERNATIVES to Government Grants and Big Pharma🧑🔬
Nonprofits attempt to fill this gap with some success, but philanthropy can only go so far.
There is little incentive to donate when donors do not have control of how their money is used...
1/🧵
2/
...or have any chance of financial benefit should the projects they fund become successful.
As a result, philanthropic donations are almost always limited to a very small portion of the donor’s wealth.
3/
While anyone can donate to a #nonprofit, private equity is a game for large investors only.
Only very recently have groups like @kickstarter emerged to allow small players to play a role in a technology’s early days.
4/
However, this hasn’t translated well into the #biomedical industry, which requires extremely large amounts of capital and comes with a high probability that no product will ever result.
University technology transfer offices also attempt to fill this gap, but typically...
5/
...range from inefficient to ineffective.
Just 11% of offices are profitable and even the best of them are only successful with less than 1% of their technologies.
In fact, the awarding and management of patents can be blamed for many issues...
6/
...ranging from excessive drug pricing to drug development’s “valley of death”.
The drug development process as it stands is ripe for disruption.
7/
A Radically Different Approach🤝
One of the best ways to take a moonshot is to look for revolutionary concepts in dramatically different fields and apply it to your own.
...and its first major successes are beginning to emerge.
VitaDAO is an organization, composed primarily of #longevity research supporters, which is applying these concepts with the goal of increasing the human healthspan.
9/
Its collective membership, rather than a CEO or a handful of grant reviewers, will decide by vote🗳 how to deploy its funding, manage its IP, and share/publish its data.